Bioregenx (BRGX) Cash from Investing Activities (2023 - 2025)
Bioregenx's Cash from Investing Activities history spans 3 years, with the latest figure at -$3057.0 for Q4 2025.
- Quarterly results put Cash from Investing Activities at -$3057.0 for Q4 2025, down 215.27% from a year ago — trailing twelve months through Dec 2025 was -$59057.0 (up 68.58% YoY), and the annual figure for FY2025 was -$59057.0, up 68.58%.
- Cash from Investing Activities for Q4 2025 was -$3057.0 at Bioregenx, up from -$6000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $2652.0 in Q4 2024 to a low of -$199363.0 in Q4 2023.
- The 3-year median for Cash from Investing Activities is -$28000.0 (2025), against an average of -$74394.2.
- The sharpest move saw Cash from Investing Activities surged 101.33% in 2024, then crashed 215.27% in 2025.
- Year by year, Cash from Investing Activities stood at -$199363.0 in 2023, then surged by 101.33% to $2652.0 in 2024, then crashed by 215.27% to -$3057.0 in 2025.
- According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$3057.0, -$6000.0, and -$50000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.